<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="nihpa"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC3691283/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Association of SNPs in the UGT1A gene cluster with total bilirubin and mortality in the Diabetes Heart Study</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691283/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Atherosclerosis"><meta name="citation_title" content="Association of SNPs in the UGT1A gene cluster with total bilirubin and mortality in the Diabetes Heart Study"><meta name="citation_authors" content="Amanda J Cox, Maggie C-Y Ng, Jianzhao Xu, Carl D Langefeld, Kenneth L Koch, Paul A Dawson, J Jeffrey Carr, Barry I Freedman, Fang-Chi Hsu, Donald W Bowden"><meta name="citation_date" content="July 2013"><meta name="citation_issue" content="1"><meta name="citation_volume" content="229"><meta name="citation_firstpage" content="155"><meta name="citation_doi" content="10.1016/j.atherosclerosis.2013.04.008"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3691283/?report=abstract"><meta name="citation_pmid" content="23642732"><meta name="DC.Title" content="Association of SNPs in the UGT1A gene cluster with total bilirubin and mortality in the Diabetes Heart Study"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="NIH Public Access"><meta name="DC.Contributor" content="Amanda J Cox"><meta name="DC.Contributor" content="Maggie C-Y Ng"><meta name="DC.Contributor" content="Jianzhao Xu"><meta name="DC.Contributor" content="Carl D Langefeld"><meta name="DC.Contributor" content="Kenneth L Koch"><meta name="DC.Contributor" content="Paul A Dawson"><meta name="DC.Contributor" content="J Jeffrey Carr"><meta name="DC.Contributor" content="Barry I Freedman"><meta name="DC.Contributor" content="Fang-Chi Hsu"><meta name="DC.Contributor" content="Donald W Bowden"><meta name="DC.Date" content="2013 Jul"><meta name="DC.Identifier" content="10.1016/j.atherosclerosis.2013.04.008"><meta name="DC.Language" content="en"><meta property="og:title" content="Association of SNPs in the UGT1A gene cluster with total bilirubin and mortality in the Diabetes Heart Study"><meta property="og:type" content="article"><meta property="og:description" content="A negative relationship between total bilirubin concentration (TBili) and CVD risk has been documented in a series of epidemiological studies. In addition, TBili is thought to be under strong genetic regulation via the UGT1A gene family, suggesting it ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691283/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><meta name="ncbi_feature" content="associated_data"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-hhspa.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC3691283/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC3691283/pdf/nihms-471000.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE8C1279DD5595B10000000005C10378.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-4"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3691283%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="pubmed">PubMed</option><option value="nuccore" class="last">Nucleotide</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a></li><li class="accid">PMC3691283</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-hhspa.png" alt="Logo of nihpa" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,57,255,75" alt="About Author manuscripts" title="About Author manuscripts" href="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" ref="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html"><area shape="rect" coords="256,57,500,75" alt="Submit a manuscript" title="Submit a manuscript" href="https://www.nihms.nih.gov/" ref="reftype=publisher&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="0,0,499,74" alt="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" title="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" href="https://www.ncbi.nlm.nih.gov/pmc/about/public-access/" ref="reftype=publisher&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">Atherosclerosis</a></span>. Author manuscript; available in PMC 2014 Jul 1.</div><div></div><div>Published in final edited form as:</div><div style="margin-left:1em"><div class="fm-vol-iss-date"><a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=23642732" target="pmc_ext" ref="reftype=publisher&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access"><span class="cit">Atherosclerosis. 2013 Jul; 229(1): 155–160. </span></a></div><span class="fm-vol-iss-date">Published online 2013 Apr 19. </span> <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1016%2Fj.atherosclerosis.2013.04.008" target="pmc_ext" ref="reftype=other&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1016/j.atherosclerosis.2013.04.008</a></span></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3691283</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS471000</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/23642732">23642732</a></div></div></div></div><h1 class="content-title">Association of SNPs in the <em>UGT1A</em> gene cluster with total bilirubin and mortality in the Diabetes Heart Study</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Cox%20AJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23642732" class="affpopup" co-rid="_co_idm140105488640544" co-class="co-affbox">Amanda J Cox</a>,<sup>a,</sup><sup>b,</sup><sup>c</sup> <a href="/pubmed/?term=Ng%20MC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23642732" class="affpopup" co-rid="_co_idm140105489582192" co-class="co-affbox">Maggie C-Y Ng</a>,<sup>a,</sup><sup>b</sup> <a href="/pubmed/?term=Xu%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23642732" class="affpopup" co-rid="_co_idm140105483854144" co-class="co-affbox">Jianzhao Xu</a>,<sup>a,</sup><sup>b</sup> <a href="/pubmed/?term=Langefeld%20CD%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23642732" class="affpopup" co-rid="_co_idm140105483851424" co-class="co-affbox">Carl D Langefeld</a>,<sup>d</sup> <a href="/pubmed/?term=Koch%20KL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23642732" class="affpopup" co-rid="_co_idm140105486074816" co-class="co-affbox">Kenneth L Koch</a>,<sup>e</sup> <a href="/pubmed/?term=Dawson%20PA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23642732" class="affpopup" co-rid="_co_idm140105490407776" co-class="co-affbox">Paul A Dawson</a>,<sup>e</sup> <a href="/pubmed/?term=Carr%20JJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23642732" class="affpopup" co-rid="_co_idm140105490405792" co-class="co-affbox">J Jeffrey Carr</a>,<sup>f</sup> <a href="/pubmed/?term=Freedman%20BI%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23642732" class="affpopup" co-rid="_co_idm140105484876032" co-class="co-affbox">Barry I Freedman</a>,<sup>g</sup> <a href="/pubmed/?term=Hsu%20FC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23642732" class="affpopup" co-rid="_co_idm140105484552064" co-class="co-affbox">Fang-Chi Hsu</a>,<sup>d</sup> and  <a href="/pubmed/?term=Bowden%20DW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23642732" class="affpopup" co-rid="_co_idm140105484550080" co-class="co-affbox">Donald W Bowden</a><sup>a,</sup><sup>b,</sup><sup>c,</sup><sup>*</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140105488640544"><h3 class="no_margin">Amanda J Cox</h3><p><sup>a</sup>Center for Human Genomics, Wake Forest School of Medicine, Winston-Salem, NC, USA</p><p><sup>b</sup>Center for Diabetes Research, Wake Forest School of Medicine, Winston-Salem, NC, USA</p><p><sup>c</sup>Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, NC, USA</p><div>Find articles by <a href="/pubmed/?term=Cox%20AJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23642732">Amanda J Cox</a></div></div><div id="_co_idm140105489582192"><h3 class="no_margin">Maggie C-Y Ng</h3><p><sup>a</sup>Center for Human Genomics, Wake Forest School of Medicine, Winston-Salem, NC, USA</p><p><sup>b</sup>Center for Diabetes Research, Wake Forest School of Medicine, Winston-Salem, NC, USA</p><div>Find articles by <a href="/pubmed/?term=Ng%20MC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23642732">Maggie C-Y Ng</a></div></div><div id="_co_idm140105483854144"><h3 class="no_margin">Jianzhao Xu</h3><p><sup>a</sup>Center for Human Genomics, Wake Forest School of Medicine, Winston-Salem, NC, USA</p><p><sup>b</sup>Center for Diabetes Research, Wake Forest School of Medicine, Winston-Salem, NC, USA</p><div>Find articles by <a href="/pubmed/?term=Xu%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23642732">Jianzhao Xu</a></div></div><div id="_co_idm140105483851424"><h3 class="no_margin">Carl D Langefeld</h3><p><sup>d</sup>Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA</p><div>Find articles by <a href="/pubmed/?term=Langefeld%20CD%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23642732">Carl D Langefeld</a></div></div><div id="_co_idm140105486074816"><h3 class="no_margin">Kenneth L Koch</h3><p><sup>e</sup>Department of Internal Medicine - Gastroenterology, Wake Forest School of Medicine, Winston-Salem, NC, USA</p><div>Find articles by <a href="/pubmed/?term=Koch%20KL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23642732">Kenneth L Koch</a></div></div><div id="_co_idm140105490407776"><h3 class="no_margin">Paul A Dawson</h3><p><sup>e</sup>Department of Internal Medicine - Gastroenterology, Wake Forest School of Medicine, Winston-Salem, NC, USA</p><div>Find articles by <a href="/pubmed/?term=Dawson%20PA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23642732">Paul A Dawson</a></div></div><div id="_co_idm140105490405792"><h3 class="no_margin">J Jeffrey Carr</h3><p><sup>f</sup>Department of Radiologic Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA</p><div>Find articles by <a href="/pubmed/?term=Carr%20JJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23642732">J Jeffrey Carr</a></div></div><div id="_co_idm140105484876032"><h3 class="no_margin">Barry I Freedman</h3><p><sup>g</sup>Department of Internal Medicine - Nephrology, Wake Forest School of Medicine, Winston-Salem, NC, USA</p><div>Find articles by <a href="/pubmed/?term=Freedman%20BI%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23642732">Barry I Freedman</a></div></div><div id="_co_idm140105484552064"><h3 class="no_margin">Fang-Chi Hsu</h3><p><sup>d</sup>Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA</p><div>Find articles by <a href="/pubmed/?term=Hsu%20FC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23642732">Fang-Chi Hsu</a></div></div><div id="_co_idm140105484550080"><h3 class="no_margin">Donald W Bowden</h3><p><sup>a</sup>Center for Human Genomics, Wake Forest School of Medicine, Winston-Salem, NC, USA</p><p><sup>b</sup>Center for Diabetes Research, Wake Forest School of Medicine, Winston-Salem, NC, USA</p><p><sup>c</sup>Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, NC, USA</p><div>Find articles by <a href="/pubmed/?term=Bowden%20DW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23642732">Donald W Bowden</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140105485733440_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140105485733440_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140105485733440_ai" style="display:none"><div class="fm-affl" id="A1" lang="en"><sup>a</sup>Center for Human Genomics, Wake Forest School of Medicine, Winston-Salem, NC, USA</div><div class="fm-affl" id="A2" lang="en"><sup>b</sup>Center for Diabetes Research, Wake Forest School of Medicine, Winston-Salem, NC, USA</div><div class="fm-affl" id="A3" lang="en"><sup>c</sup>Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, NC, USA</div><div class="fm-affl" id="A4" lang="en"><sup>d</sup>Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA</div><div class="fm-affl" id="A5" lang="en"><sup>e</sup>Department of Internal Medicine - Gastroenterology, Wake Forest School of Medicine, Winston-Salem, NC, USA</div><div class="fm-affl" id="A6" lang="en"><sup>f</sup>Department of Radiologic Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA</div><div class="fm-affl" id="A7" lang="en"><sup>g</sup>Department of Internal Medicine - Nephrology, Wake Forest School of Medicine, Winston-Salem, NC, USA</div><div id="CR1"><sup>*</sup><strong>Corresponding Author at:</strong> Department of Biochemistry, Wake Forest School of Medicine Medical Center Boulevard, Winston Salem, NC, USA, 27157 Tel: +1 336-713-7507 Fax: +1 336-713-7544 <a href="mailto:dev@null" data-email="ude.htlaehekaw@nedwobd" class="oemail">ude.htlaehekaw@nedwobd</a></div></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="permissions fm-panel half_rhythm hide" id="idm140105485733440_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright notice</a> </div><div><a href="#FN1">Publisher's Disclaimer</a></div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>The publisher's final edited version of this article is available  at <a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=23642732" target="pmc_ext" ref="reftype=publisher&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access">Atherosclerosis</a></div><div>See other articles in PMC that <a href="/pmc/articles/PMC3691283/citedby/">cite</a> the published article.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="ui-helper-clearfix" id="ui-ncbiinpagenav-heading-3">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>01.</strong></div><div><a href="/pmc/articles/PMC3691283/bin/NIHMS471000-supplement-01.doc" data-ga-action="click_feat_suppl">NIHMS471000-supplement-01.doc</a><span style="color:gray"> (230K)</span></div><div class="small guid">GUID:&nbsp;CDC6FC57-AD37-4683-9906-B519B2139171</div></div></dd></dl></div><div id="idm140105483330784" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140105483330784title">Abstract</h2><!--article-meta--><div><div id="S1" class="sec sec-first"><h3 id="S1title">Objective</h3><p id="P1" class="p p-first-last">A negative relationship between total bilirubin concentration (TBili) and CVD risk has been documented in a series of epidemiological studies. In addition, TBili is thought to be under strong genetic regulation via the <em>UGT1A</em> gene family, suggesting it may be a heritable CVD risk factor. However, few studies directly relate TBili-associated <em>UGT1A</em> variants to CVD severity or outcome. This study replicated the genetic association for TBili in the Diabetes Heart Study (DHS), and examined the relationships of TBili-associated SNPs with measures of subclinical CVD and mortality.</p></div><div id="S2" class="sec"><h3 id="S2title">Methods</h3><p id="P2" class="p p-first-last">This investigation included 1220 self-described European American (EA) individuals from the DHS, a family-based study examining risk for macrovascular complications in type 2 diabetes (T2D). Genetic associations with TBili were examined using the Affymetrix Genome-wide Human SNP Array 5.0 and the Illumina Infinium Human Exome beadchip v1.0. Subsequent analyses assessed the relationships of the top TBili-associated SNPs with measures of vascular calcified plaque and mortality.</p></div><div id="S3" class="sec"><h3 id="S3title">Results</h3><p id="P3" class="p p-first-last">A genome-wide association study (GWAS) detected 18 SNPs within the <em>UGT1A</em> gene family associated with TBili at p&lt;5×10<sup>-8</sup>. The top hit was rs887829 (p=8.67×10<sup>-20</sup>). There was no compelling evidence of association between the top TBili-associated SNPs and vascular calcified plaque (p=0.05-0.88). There was, however, evidence of association with all-cause mortality (p=0.0004-0.06), the top hit being rs2741034.</p></div><div id="S4" class="sec sec-last"><h3 id="S4title">Conclusion</h3><p id="P4" class="p p-first-last">These findings support a potential role for <em>UGT1A</em> genetic variants in risk for mortality in T2D. Further quantification of the extent of CVD risk conferred by <em>UGT1A</em> gene family variants in a high risk cohort with T2D is still required.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">bilirubin, genetics, cardiovascular disease, vascular calcified plaque</span></div></div><div id="S5" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S5title">1. INTRODUCTION</h2><p id="P5" class="p p-first">Bilirubin, the end product of heme catabolism in the systemic circulation [<a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991684">1</a>], has been documented as a risk factor for cardiovascular disease (CVD). The association of low total bilirubin concentrations (TBili) with increased CVD risk was initially reported in an investigation involving an asymptomatic, male population (n=877) with &lt;35% having prevalent coronary artery disease (CAD) defined by angiography [<a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991711">2</a>]. This negative association was subsequently confirmed in a smaller familial CAD sample (161 CAD cases and 155 controls) [<a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991695">3</a>] and has been further replicated and confirmed in both larger and prospective investigations (see Schwertner and Vitek [<a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991674">4</a>] for review of key studies), including in populations with clinical hyperbilirubinemia [<a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991682">5</a>]. The increased risk for CVD associated with lower bilirubin concentrations has also been observed in the context of subclinical CVD with a meta-analysis, utilizing data from male subjects only, supporting a clear negative association between serum bilirubin concentrations and severity of atherosclerosis [<a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_352555973">6</a>]. Significant negative associations have also reported from studies of Asian populations utilizing both coronary artery calcified plaque (n=637) [<a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991686">7</a>, <a href="#R8" rid="R8" class=" bibr popnode">8</a>] and indices of carotid intima-media thickening (n=172) [<a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991699">9</a>].</p><p id="P6">The mechanisms by which TBili contributes to reduced CVD risk are likely to include both antioxidant actions [<a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991680">1</a>, <a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991678">4</a>], including the prevention of LDL oxidation [<a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991672">10</a>, <a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991697">11</a>], and anti-inflammatory effects [<a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991683">12</a>]. Whether the TBili-CVD risk paradigm is similarly relevant in patients with type 2 diabetes (T2D), a disease characterized by excess CVD-mortality, increased inflammation [<a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991700">13</a>, <a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_500473492">14</a>] and where abnormal liver function measures have been previously reported [<a href="#R15" rid="R15" class=" bibr popnode">15</a>], has not been thoroughly investigated. One small study in a diabetic sample of European origin (n=80) supports the negative association between TBili and carotid intima media thickness [<a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991712">16</a>]. More recently, TBili concentrations were found to be negatively associated with lower limb amputation, reflecting peripheral vascular disease, in the Fenofibrate Intervention and Event Lowering in Diabetes Study [<a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991713">17</a>]. Finally, the report of a negative relationship between TBili and glycated hemoglobin levels in a Korean sample with T2D [<a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991702">18</a>] supports the need for further investigation of the TBili-CVD risk paradigm in diabetic populations.</p><p id="P7" class="p p-last">Bilirubin concentrations are thought to be under strong genetic regulation. Polymorphism of a TA repeat sequence in the <em>UGT1A1</em> gene promoter (UGT1A1*28; rs8175347) has been identified as an important risk factor in Gilbert Syndrome, a benign clinical hyperbilirubinemia [<a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991687">19</a>], with increasing repeat length associated with decreased gene promoter activity [<a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991694">20</a>]. More recently, genome-wide association studies (GWAS) have also shown strong and reproducible associations between single nucleotide polymorphism (SNPs) in the <em>UGT1A</em> gene cluster and TBili concentrations [<a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991708">21</a>-<a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991689">23</a>]. However, despite the multiple epidemiological studies linking TBili to CVD risk, few existing reports directly relate the TBili-associated <em>UGT1A</em> gene family variants to measures of CVD severity or outcome. Association between the UGT1A1*28 microsatellite and coronary heart disease has been investigated in both the Rotterdam [<a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991671">24</a>] and Framingham offspring [<a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991673">11</a>] studies, with conflicting results. We are unaware of any similar studies involving the GWAS-identified bilirubin-associated <em>UGT1A</em> SNPs. As such, we sought to replicate the TBili-<em>UGT1A</em> association in the Diabetes Heart Study (DHS), a family based study examining risk for macrovascular complications in T2D, and examine the relationships of the TBili-<em>UGT1A</em> associated SNPs with measures of subclinical CVD and mortality.</p></div><div id="S6" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S6title">2. METHODS</h2><div id="S7" class="sec sec-first"><h3 id="S7title">2.1 Study Design and Sample</h3><p id="P8" class="p p-first">This investigation included 1,220 self-described European American (EA) individuals from 475 families comprising the Diabetes Heart Study (DHS) cohort. Briefly, the DHS includes siblings concordant for T2D, but without advanced renal insufficiency. When possible, unaffected siblings were also recruited. T2D was clinically defined as diabetes developing after the age of 35 years and treated with insulin and/or oral agents, in the absence of historical evidence of ketoacidosis. Ascertainment and recruitment have been previously described in detail [<a href="#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991705">25</a>, <a href="#R26" rid="R26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_544190355">26</a>].</p><p id="P9" class="p p-last">Study protocols were approved by the Institutional Review Board at Wake Forest School of Medicine, and all participants provided written informed consent prior to participation. Participant examinations were conducted in the General Clinical Research Center of the Wake Forest Baptist Medical Center, and included interviews for medical history (including self-reported history of prior CVD events or intervention) and health behaviors, anthropometric measures, resting blood pressure, electrocardiography, fasting blood sampling for laboratory analyses, and spot urine collection. Standard laboratory analyses included fasting glucose, glycated hemoglobin (HbA<sub>1C</sub>), blood lipids and measures of liver function, including total bilirubin concentrations, alkaline phosphatase (ALP), serum glutamic oxaloacetic transaminase (SGOT) and serum glutamic pyruvate transaminase (SGPT). Total (conjugated and ungonjugated) bilirubin concentrations were determined using the timed-endpoint diazo method with 2,5-dicholophenyl diazonium. Measures of subclinical CVD included coronary artery calcified plaque (CAC), carotid artery calcified plaque (CarCP) and infra-renal abdominal aortic calcified plaque (AACP), measured using fast-gated helical CT scanners, with calcium scores calculated as previously described [<a href="#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991714">27</a>, <a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991696">28</a>]. Not all measurements were available for all participants.</p></div><div id="S8" class="sec"><h3 id="S8title">2.2 Mortality</h3><p id="P10" class="p p-first-last">Vital status was determined for all participants from the National Social Security Death Index maintained by the United States Social Security Administration. For those participants confirmed as deceased, length of follow-up was determined from the date of the initial study visit to date of death. For deceased participants, copies of death certificates were obtained from relevant county Vital Records Offices to confirm cause of death. For all other participants the length of follow-up was determined from the date of the initial study visit to the end of 2011. Cause of death was categorized based on information contained in death certificates as CVD-mortality (myocardial infarction, congestive heart failure, cardiac arrhythmia, sudden cardiac death, peripheral vascular disease, and stroke) or either cancer, infection, end-stage renal disease, accidental, or other (including obstructive pulmonary disease, pulmonary fibrosis, liver failure and Alzheimer's dementia).</p></div><div id="S9" class="sec"><h3 id="S9title">2.3 Genetic Analysis</h3><p id="P11" class="p p-first">Genomic DNA was purified from whole blood samples using the PUREGENE DNA isolation kit (Gentra, Inc., Minneapolis, MN). DNA concentration was quantified using standardized fluorometric readings on a Hoefer DyNA Quant 200 fluorometer (Hoefer Pharmacia Biotech Inc., San Francisco, CA). Genotyping was completed in two stages (i) using the Affymetrix genotyping platform and the Affymetrix Genome-wide Human SNP Array 5.0 (Affymetrix, CA, USA) (the GWAS set) and (ii) using the Illumina Infinium Human Exome beadchip v1.0 (Illumina, Ca, USA) (the Exome set).</p><p id="P12">For the GWAS set, genotype calling was completed using the BRLLM-P algorithm in Genotyping Console v4.0 (Affymetrix). Samples failing to meet an intensity quality control (QC) threshold (n=4) were not included for genotype calling and those failing to meet a minimum acceptable call rate of 95% (n=3) were excluded from further analyses. An additional 39 samples were included as blind duplicates within the genotyping set to serve as quality controls; the concordance rate for these blind duplicates was 99.0 ± 0.72% (mean ± SD).</p><p id="P13">For the Exome set, genotype calling was completed using Genome Studio Software v1.9.4 (Illumina). Samples failing to meet a minimum acceptable call rate of 98% (n=3) were excluded from further analyses. An additional 58 samples were included as blind duplicates within the genotyping set to serve as quality controls; the concordance rate for blind duplicates was 99.9 ± 0.0001% (mean ± SD).</p><p id="P14" class="p p-last">Following genotype calling, exploratory analyses of genotype data were performed using PLINK v1.07 (<a href="http://pngu.mgh.harvard.edu/purcell/plink/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://pngu.mgh.harvard.edu/purcell/plink/</a>) and identified samples with poor quality genotype calls, gender errors, or unclear/unexpected sibling relationships; all of these were excluded from further analysis. A total of 1,180 samples with available genotyping data in both the GWAS and Exome sets were analyzed. For the GWAS set, exclusion criteria for SNP performance included call rate &lt;95% (n=11,085), Hardy-Weinberg Equilibrium p-value &lt;1×10<sup>-6</sup> (n=332), and minor allele frequency &lt;0.01 (n=57,382); 371,951 SNPs were retained for analysis. For the Exome set, exclusion criteria for SNP performance included call rate &lt;99% (n=972), monomorphic SNPs (n=157,754) and Hardy-Weinberg Equilibrium p-value &lt;1×10<sup>-6</sup> (n=26); 88,483 SNPs were retained for analysis.</p></div><div id="S10" class="sec sec-last"><h3 id="S10title">2.4 Statistical Analysis</h3><p id="P15" class="p p-first">Summary statistics were calculated including means and standard deviations (SD) for continuous variables, and count and percentages for categorical variables. Continuous variables were transformed prior to analysis to approximate conditional normality. Due to the inclusion of related individuals in this study, marginal models with incorporation of generalized estimating equations (GEE) were used to describe associations between the TBili and continuous measures of subclinical CVD (CAC, CarCP and AACP). In order to compare the relative effect, dependent variables (CAC, CarCP, AACP) were standardized for analysis of phenotypic associations. Analysis of the univariate associations between TBili and measures of vascular calcified plaque were undertaken initially. Each of these associations was then adjusted for (i) age, sex and BMI (partially adjusted) and (ii) age sex, BMI, T2D affected status, hypertension, current smoking and dyslipidemia (fully adjusted). Cox proportional hazards models with sandwich-based variance estimation were used to examine the relationships between TBili and all-cause mortality, as well as between TBili and either CVD-mortality or non-CVD mortality. Cox proportional hazards models were partially and fully adjusted as described above. The same analyses were repeated restricting to the T2D affected individuals only. SAS version 9.2 (SAS Institute Inc., Cary, NC) was used for the analysis. Statistical significance was accepted a p&lt;0.05.</p><p id="P16" class="p p-last">Genetic association analyses were performed using variance components methods as implemented in Sequential Oligogenic Linkage Analysis Routines (SOLAR) version 6.3.4 (Texas Biomedical Research Institute, San Antonio, Tx, USA) to account for family relationships. For genome-wide TBili association an additive model of inheritance was assumed with adjustment for age, sex and T2D affected status. The relationship between the top TBili-associated SNPs (p&lt;5×10<sup>-8</sup>) with measures of vascular calcified plaque and mortality were examined, also under an additive model, with adjustment for age, sex and T2D affected status. These analyses were repeated with additional adjustment for TBili to further account for the potential contribution of TBili to the phenotypic variance. All analyses were repeated restricting to the T2D affected individuals only. Genome-wide significance was accepted at p&lt;5×10<sup>-8</sup>.</p></div></div><div id="S11" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S11title">3. RESULTS</h2><p id="P17" class="p p-first">The demographic and clinical characteristics of the DHS cohort are presented in <a href="/pmc/articles/PMC3691283/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>. As anticipated in a T2D-enriched sample, a predominance of traditional CVD risk factors were evident including high body mass index (BMI), hypertension, dyslipidemia and prior CVD events. Scores for CAC, CarCP and AACP reflect a substantial burden of subclinical CVD in these diabetes-affected individuals and their siblings. Average total bilirubin concentrations were 13.9 ± 5.1 μmol/L and were within the laboratory reference range (3.4-20.5 μmol/L). Average values for other measured liver enzymes (ALP, SGOT, SGPT) were also within established laboratory reference ranges. This cohort was followed for 8.2 ± 2.6 yrs (mean ± SD) over which time 247 (20.9%) participants were deceased, 107 (9.1%) from CVD causes.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p6">Demographic characteristics of the 1,180 DHS participants with genotype data.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140105479654096" class="xtable"><table frame="hsides" rules="cols" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="top" align="left"></th><th rowspan="1" colspan="1" valign="top" align="center">Mean ± SD or %</th><th rowspan="1" colspan="1" valign="top" align="center">Median (inter-quartile range)</th></tr><tr><th colspan="3" rowspan="1" valign="top" align="left"><hr></th></tr></thead><tbody><tr><td colspan="3" rowspan="1" valign="top" align="left">
<strong>Demographic Information</strong>
</td></tr><tr><td colspan="3" rowspan="1" valign="top" align="left"><hr></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Age (years)</td><td rowspan="1" colspan="1" valign="top" align="center">62.1 ± 9.3</td><td rowspan="1" colspan="1" valign="top" align="center">62.6 (55.7-69.1)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Gender (% female)</td><td rowspan="1" colspan="1" valign="top" align="center">53.5%</td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Type 2 diabetes affected (%)</td><td rowspan="1" colspan="1" valign="top" align="center">83.7%</td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Diabetes Duration (years)</td><td rowspan="1" colspan="1" valign="top" align="center">10.5 ± 7.2</td><td rowspan="1" colspan="1" valign="top" align="center">8 (5-14)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">% smoking (current or past)</td><td rowspan="1" colspan="1" valign="top" align="center">58.7%</td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Self-reported history of prior CVD</td><td rowspan="1" colspan="1" valign="top" align="center">38.9%</td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Deceased</td><td rowspan="1" colspan="1" valign="top" align="center">20.9%</td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Deceased (CVD causes)</td><td rowspan="1" colspan="1" valign="top" align="center">9.1%</td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td colspan="3" rowspan="1" valign="top" align="left">
<hr><strong>Body Composition</strong><hr>
</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Height (cm)</td><td rowspan="1" colspan="1" valign="top" align="center">168.6 ± 9.7</td><td rowspan="1" colspan="1" valign="top" align="center">168.2 (161.0-175.7)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Weight (kg)</td><td rowspan="1" colspan="1" valign="top" align="center">90.5 ± 20.3</td><td rowspan="1" colspan="1" valign="top" align="center">88.1 (76.0-103.9)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">BMI (kg/m<sup>2</sup>)</td><td rowspan="1" colspan="1" valign="top" align="center">31.8 ± 6.5</td><td rowspan="1" colspan="1" valign="top" align="center">30.7 (27.2-35.6)</td></tr><tr><td colspan="3" rowspan="1" valign="top" align="left">
<hr><strong>Medications</strong><hr>
</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Lipid Lowering (%)</td><td rowspan="1" colspan="1" valign="top" align="center">44.7%</td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Anti-hypertensive (%)</td><td rowspan="1" colspan="1" valign="top" align="center">62.6%</td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td colspan="3" rowspan="1" valign="top" align="left">
<hr><strong>Blood Pressure</strong><hr>
</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Systolic BP (mmHg)</td><td rowspan="1" colspan="1" valign="top" align="center">139 ± 19</td><td rowspan="1" colspan="1" valign="top" align="center">138 (126-151)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Diastolic BP (mmHg)</td><td rowspan="1" colspan="1" valign="top" align="center">73 ± 10</td><td rowspan="1" colspan="1" valign="top" align="center">72 (66-80)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Hypertension (%)</td><td rowspan="1" colspan="1" valign="top" align="center">85.6%</td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td colspan="3" rowspan="1" valign="top" align="left">
<hr><strong>Blood Biochemistry</strong><hr>
</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Glucose (mg/dL)</td><td rowspan="1" colspan="1" valign="top" align="center">139.4 ± 55.4</td><td rowspan="1" colspan="1" valign="top" align="center">127 (102-164)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Hemoglobin A<sub>1C</sub> (%)</td><td rowspan="1" colspan="1" valign="top" align="center">7.3 ± 1.8</td><td rowspan="1" colspan="1" valign="top" align="center">6.9 (6.1-8.1)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Total Cholesterol (mg/ dL)</td><td rowspan="1" colspan="1" valign="top" align="center">186.6 ± 42.6</td><td rowspan="1" colspan="1" valign="top" align="center">183.0 (158.8-209.3)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">HDL-cholesterol (mg/dL)</td><td rowspan="1" colspan="1" valign="top" align="center">43.1 ± 12.6</td><td rowspan="1" colspan="1" valign="top" align="center">41 (35-50)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">LDL-cholesterol (mg/dL)</td><td rowspan="1" colspan="1" valign="top" align="center">104.9 ± 32.7</td><td rowspan="1" colspan="1" valign="top" align="center">102 (81-125)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Triglycerides (mg/dL)</td><td rowspan="1" colspan="1" valign="top" align="center">201.0 ± 132.7</td><td rowspan="1" colspan="1" valign="top" align="center">171 (116-242)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Total Bilirubin (umol/L)</td><td rowspan="1" colspan="1" valign="top" align="center">13.9 ± 5.1</td><td rowspan="1" colspan="1" valign="top" align="center">13.7 (10.3-15.4)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">ALP (U/L)</td><td rowspan="1" colspan="1" valign="top" align="center">78 ± 25</td><td rowspan="1" colspan="1" valign="top" align="center">76 (61-91)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">SGOT/AST (U/L)</td><td rowspan="1" colspan="1" valign="top" align="center">27 ± 12</td><td rowspan="1" colspan="1" valign="top" align="center">27 (20-30)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">SGPT/ALT (U/L)</td><td rowspan="1" colspan="1" valign="top" align="center">24 ± 13</td><td rowspan="1" colspan="1" valign="top" align="center">24 (17-27)</td></tr><tr><td colspan="3" rowspan="1" valign="top" align="left">
<hr><strong>Vascular Imaging – Calcified Plaque (CP)</strong><hr>
</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Coronary Artery CP</td><td rowspan="1" colspan="1" valign="top" align="center">1672 ± 3179</td><td rowspan="1" colspan="1" valign="top" align="center">348 (33-2043)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Carotid Artery CP</td><td rowspan="1" colspan="1" valign="top" align="center">313 ± 671</td><td rowspan="1" colspan="1" valign="top" align="center">44 (0-297)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Abdominal Aortic CP</td><td rowspan="1" colspan="1" valign="top" align="center">11158 ± 15939</td><td rowspan="1" colspan="1" valign="top" align="center">4020 (550-16040)</td></tr></tbody></table></div><div id="largeobj_idm140105479654096" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3691283/table/T1/?report=objectonly">Open in a separate window</a></div></div><p id="P18">In unadjusted analyses a positive association was observed between TBili and both CAC and CarCP. This was negated following adjustment for traditional CVD risk factors including age, sex, BMI, T2D affected status, current smoking, hypertension and dyslipidemia (<a href="/pmc/articles/PMC3691283/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>). There were no significant associations between TBili and either all-cause, CVD-mortality, or non-CVD mortality. These relationships were essentially unchanged when analyses were restricted to T2D affected individuals only (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Material, Table 1</a>).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="__p7">Associations between total bilirubin and measures of vascular calcified plaque and mortality (unadjusted and adjusted models) presented as beta (β) estimate and standard error (SE) for continuous traits and hazard ratio (HR) and 95 % confidence interval (CI) for discrete traits.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140105491168656" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="top" align="center"></th><th colspan="2" rowspan="1" valign="top" align="center">Unadjusted</th><th colspan="2" rowspan="1" valign="top" align="center">Partially Adjusted<sup><sup>*</sup></sup></th><th colspan="2" rowspan="1" valign="top" align="center">Fully Adjusted<sup>†</sup></th></tr><tr><th colspan="7" rowspan="1" valign="top" align="left"><hr></th></tr><tr><th rowspan="1" colspan="1" valign="top" align="center"></th><th rowspan="1" colspan="1" valign="top" align="center">β (SE)</th><th rowspan="1" colspan="1" valign="top" align="center">p-value</th><th rowspan="1" colspan="1" valign="top" align="center">β (SE)</th><th rowspan="1" colspan="1" valign="top" align="center">p-value</th><th rowspan="1" colspan="1" valign="top" align="center">β (SE)</th><th rowspan="1" colspan="1" valign="top" align="center">p-value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="center">CAC</td><td rowspan="1" colspan="1" valign="top" align="center">0.784 (0.201)</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.0001</td><td rowspan="1" colspan="1" valign="top" align="center">0.121 (0.178)</td><td rowspan="1" colspan="1" valign="top" align="center">0.50</td><td rowspan="1" colspan="1" valign="top" align="center">0.163 (0.180)</td><td rowspan="1" colspan="1" valign="top" align="center">0.37</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">CarCP</td><td rowspan="1" colspan="1" valign="top" align="center">0.553 (0.200)</td><td rowspan="1" colspan="1" valign="top" align="center">0.0056</td><td rowspan="1" colspan="1" valign="top" align="center">0.158 (0.181)</td><td rowspan="1" colspan="1" valign="top" align="center">0.38</td><td rowspan="1" colspan="1" valign="top" align="center">0.188 (0.181)</td><td rowspan="1" colspan="1" valign="top" align="center">0.30</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">AACP</td><td rowspan="1" colspan="1" valign="top" align="center">0.199 (0.234)</td><td rowspan="1" colspan="1" valign="top" align="center">0.39</td><td rowspan="1" colspan="1" valign="top" align="center">-0.205 (0.209)</td><td rowspan="1" colspan="1" valign="top" align="center">0.33</td><td rowspan="1" colspan="1" valign="top" align="center">-0.111 (0.212)</td><td rowspan="1" colspan="1" valign="top" align="center">0.60</td></tr></tbody></table></div><div id="largeobj_idm140105491168656" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3691283/table/T2/?report=objectonly">Open in a separate window</a></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140105491395648" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="top" align="center"></th><th rowspan="1" colspan="1" valign="top" align="center">HR (CI)</th><th rowspan="1" colspan="1" valign="top" align="center">p-value</th><th rowspan="1" colspan="1" valign="top" align="center">HR (CI)</th><th rowspan="1" colspan="1" valign="top" align="center">p-value</th><th rowspan="1" colspan="1" valign="top" align="center">HR (CI)</th><th rowspan="1" colspan="1" valign="top" align="center">p-value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="center">All-cause mortality</td><td rowspan="1" colspan="1" valign="top" align="center">2.06 (0.85-5.00)</td><td rowspan="1" colspan="1" valign="top" align="center">0.11</td><td rowspan="1" colspan="1" valign="top" align="center">1.29 (0.51-3.25)</td><td rowspan="1" colspan="1" valign="top" align="center">0.60</td><td rowspan="1" colspan="1" valign="top" align="center">1.59 (0.63-4.01)</td><td rowspan="1" colspan="1" valign="top" align="center">0.32</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">CVD mortality</td><td rowspan="1" colspan="1" valign="top" align="center">1.53 (0.40-5.89)</td><td rowspan="1" colspan="1" valign="top" align="center">0.54</td><td rowspan="1" colspan="1" valign="top" align="center">0.89 (0.23-3.57)</td><td rowspan="1" colspan="1" valign="top" align="center">0.89</td><td rowspan="1" colspan="1" valign="top" align="center">0.87 (0.23-3.34)</td><td rowspan="1" colspan="1" valign="top" align="center">0.84</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">Non-CVD mortality</td><td rowspan="1" colspan="1" valign="top" align="center">1.60 (0.86-2.99)</td><td rowspan="1" colspan="1" valign="top" align="center">0.14</td><td rowspan="1" colspan="1" valign="top" align="center">1.35 (0.72-2.55)</td><td rowspan="1" colspan="1" valign="top" align="center">0.35</td><td rowspan="1" colspan="1" valign="top" align="center">1.55 (0.82-2.92)</td><td rowspan="1" colspan="1" valign="top" align="center">0.18</td></tr></tbody></table></div><div id="largeobj_idm140105491395648" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3691283/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p8">CAC = coronary artery calcified plaque, CarCP= carotid artery calcified plaque. AACP = abdominal aortic calcified plaque</p><div id="TFN1"><sup>*</sup>adjusted for age, sex, BMI</div><div id="TFN2"><sup>†</sup>adjusted for age, sex, BMI, T2D affected status, current smoking, hypertension, dyslipidemia</div></div></div><p id="P19">Genetic association analysis revealed 14 SNPs within the <em>UGT1A</em> gene cluster to be associated with TBili at p&lt;5×10<sup>-8</sup> for the GWAS set (<a href="/pmc/articles/PMC3691283/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1a</span></a>); the most strongly associated SNP was rs887829 (p=8.67×10<sup>-20</sup>). For the Exome set, six SNPs within the <em>UGT1A</em> gene cluster were also associated with TBili at p&lt;5×10<sup>-8</sup> (<a href="/pmc/articles/PMC3691283/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1b</span></a>). Two of these SNPs (rs887829 and rs6759892) were contained within the GWAS set. All associated SNPs were in at least moderate linkage disequilibrium (LD; r<sup>2</sup>=0.2-0.8) with the lead GWAS SNP rs887829 (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Material, Figure 1</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC3691283/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140105489956976" class="figure"><a href="/pmc/articles/PMC3691283/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3691283_nihms-471000-f0001.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms-471000-f0001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3691283/bin/nihms-471000-f0001.jpg"></a></div><div id="largeobj_idm140105489956976" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3691283/figure/F1/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC3691283/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p5">Manhattan plots for genotypic associations with total Bilirubin concentrations for the GWAS and Exome data sets</p></div></div></div><p id="P20" class="p p-last">There was no compelling evidence of association between the 18 top TBili-associated SNPs and CAC at the genome-wide level (<a href="/pmc/articles/PMC3691283/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>), however, following adjustment for TBili, five SNPs trended towards nominal association (p&lt;0.05) (<a href="/pmc/articles/PMC3691283/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>). There was no evidence supporting association between the 18 top TBili-associated SNPs and either CarCP (p=0.08-0.89) or AACP (p=0.14-0.95). Finally, modest associations were observed between the 18 top TBili-associated SNPs and all-cause mortality (<a href="/pmc/articles/PMC3691283/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>), but not with CVD-mortality (p=0.04-0.55). The associations with mortality were also enhanced following adjustment for TBili (<a href="/pmc/articles/PMC3691283/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>). Bilirubin concentrations and all-cause mortality rates by SNP are included in the Supplementary Material (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Material, Table 2</a>). Patterns were generally similar when analyses were restricted to T2D affected individuals only (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Material, Table 3</a>).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T3"><h3>Table 3</h3><!--caption a7--><div class="caption"><p id="__p9"><em>UGT1A</em> gene cluster SNP associations with total bilirubin concentrations (TBili), coronary artery calcified plaque (CAC) and mortality.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140105483357376" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="top" align="center"></th><th rowspan="1" colspan="1" valign="top" align="center"></th><th rowspan="1" colspan="1" valign="top" align="center"></th><th rowspan="1" colspan="1" valign="top" align="center"></th><th rowspan="1" colspan="1" valign="top" align="center"></th><th rowspan="1" colspan="1" valign="top" align="center"></th><th colspan="5" rowspan="1" valign="top" align="center">Association p-values<hr></th></tr><tr><th rowspan="1" colspan="1" valign="top" align="center">SNP</th><th rowspan="1" colspan="1" valign="top" align="center">Position</th><th rowspan="1" colspan="1" valign="top" align="center">Location</th><th rowspan="1" colspan="1" valign="top" align="center">Alleles (Maj/Min)</th><th rowspan="1" colspan="1" valign="top" align="center">MAF</th><th rowspan="1" colspan="1" valign="top" align="center">Source</th><th rowspan="1" colspan="1" valign="top" align="center">TBili<sup><sup>*</sup></sup></th><th rowspan="1" colspan="1" valign="top" align="center">CAC<sup><sup>*</sup></sup></th><th rowspan="1" colspan="1" valign="top" align="center">CAC<sup>†</sup></th><th rowspan="1" colspan="1" valign="top" align="center">All-cause mortality<sup><sup>*</sup></sup></th><th rowspan="1" colspan="1" valign="top" align="center">All-cause mortality<sup>†</sup></th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="center">rs2741023</td><td rowspan="1" colspan="1" valign="top" align="center">234516714</td><td rowspan="1" colspan="1" valign="top" align="center">upstream</td><td rowspan="1" colspan="1" valign="top" align="center">G/A</td><td rowspan="1" colspan="1" valign="top" align="center">0.368</td><td rowspan="1" colspan="1" valign="top" align="center">GWAS</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>2.55×10<sup>-10</sup></strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">0.32</td><td rowspan="1" colspan="1" valign="top" align="center">0.17</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.0006</strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>7.1 ×10<sup>-05</sup></strong>
</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs2741029</td><td rowspan="1" colspan="1" valign="top" align="center">234530160</td><td rowspan="1" colspan="1" valign="top" align="center">intronic</td><td rowspan="1" colspan="1" valign="top" align="center">A/C</td><td rowspan="1" colspan="1" valign="top" align="center">0.289</td><td rowspan="1" colspan="1" valign="top" align="center">GWAS</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>2.18×10<sup>-9</sup></strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">0.88</td><td rowspan="1" colspan="1" valign="top" align="center">0.47</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.002</strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.0004</strong>
</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs2741034</td><td rowspan="1" colspan="1" valign="top" align="center">234548814</td><td rowspan="1" colspan="1" valign="top" align="center">intronic</td><td rowspan="1" colspan="1" valign="top" align="center">A/G</td><td rowspan="1" colspan="1" valign="top" align="center">0.278</td><td rowspan="1" colspan="1" valign="top" align="center">GWAS</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>1.49×10<sup>-9</sup></strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">0.31</td><td rowspan="1" colspan="1" valign="top" align="center">0.16</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.0004</strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>4.5 ×10<sup>-05</sup></strong>
</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs2741045</td><td rowspan="1" colspan="1" valign="top" align="center">234580140</td><td rowspan="1" colspan="1" valign="top" align="center">intronic</td><td rowspan="1" colspan="1" valign="top" align="center">C/T</td><td rowspan="1" colspan="1" valign="top" align="center">0.294</td><td rowspan="1" colspan="1" valign="top" align="center">GWAS</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>2.02×10<sup>-14</sup></strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">0.29</td><td rowspan="1" colspan="1" valign="top" align="center">0.14</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.002</strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.0002</strong>
</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs10197460</td><td rowspan="1" colspan="1" valign="top" align="center">234589190</td><td rowspan="1" colspan="1" valign="top" align="center">intronic</td><td rowspan="1" colspan="1" valign="top" align="center">G/T</td><td rowspan="1" colspan="1" valign="top" align="center">0.388</td><td rowspan="1" colspan="1" valign="top" align="center">GWAS</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>3.70×10<sup>-13</sup></strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">0.05</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.02</strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.01</strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.002</strong>
</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs6736508</td><td rowspan="1" colspan="1" valign="top" align="center">234595747</td><td rowspan="1" colspan="1" valign="top" align="center">intronic</td><td rowspan="1" colspan="1" valign="top" align="center">G/A</td><td rowspan="1" colspan="1" valign="top" align="center">0.405</td><td rowspan="1" colspan="1" valign="top" align="center">GWAS</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>4.71×10<sup>-13</sup></strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">0.06</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.03</strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.03</strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.007</strong>
</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs7563561</td><td rowspan="1" colspan="1" valign="top" align="center">234598991</td><td rowspan="1" colspan="1" valign="top" align="center">intronic</td><td rowspan="1" colspan="1" valign="top" align="center">T/G</td><td rowspan="1" colspan="1" valign="top" align="center">0.406</td><td rowspan="1" colspan="1" valign="top" align="center">GWAS</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>7.18×10<sup>-13</sup></strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">0.06</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.03</strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.03</strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.006</strong>
</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs7608175</td><td rowspan="1" colspan="1" valign="top" align="center">234599089</td><td rowspan="1" colspan="1" valign="top" align="center">intronic</td><td rowspan="1" colspan="1" valign="top" align="center">C/G</td><td rowspan="1" colspan="1" valign="top" align="center">0.405</td><td rowspan="1" colspan="1" valign="top" align="center">GWAS</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>7.45×10<sup>-13</sup></strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">0.06</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.03</strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.04</strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.007</strong>
</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs6759892</td><td rowspan="1" colspan="1" valign="top" align="center">234601669</td><td rowspan="1" colspan="1" valign="top" align="center">Misense<sup>¶</sup></td><td rowspan="1" colspan="1" valign="top" align="center">T/G</td><td rowspan="1" colspan="1" valign="top" align="center">0.406</td><td rowspan="1" colspan="1" valign="top" align="center">GWAS<sup>§</sup></td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>7.93×10<sup>-13</sup></strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">0.05</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.02</strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.03</strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.007</strong>
</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs2070959</td><td rowspan="1" colspan="1" valign="top" align="center">234602191</td><td rowspan="1" colspan="1" valign="top" align="center">Misense<sup>¶</sup></td><td rowspan="1" colspan="1" valign="top" align="center">A/G</td><td rowspan="1" colspan="1" valign="top" align="center">0.313</td><td rowspan="1" colspan="1" valign="top" align="center">Exome</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>2.48×10<sup>-14</sup></strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">0.29</td><td rowspan="1" colspan="1" valign="top" align="center">0.11</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.003</strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.0006</strong>
</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs1105879</td><td rowspan="1" colspan="1" valign="top" align="center">234602202</td><td rowspan="1" colspan="1" valign="top" align="center">Misense<sup>¶</sup></td><td rowspan="1" colspan="1" valign="top" align="center">A/C</td><td rowspan="1" colspan="1" valign="top" align="center">0.334</td><td rowspan="1" colspan="1" valign="top" align="center">Exome</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>1.21×10<sup>-14</sup></strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">0.27</td><td rowspan="1" colspan="1" valign="top" align="center">0.11</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.01</strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.003</strong>
</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs6744284</td><td rowspan="1" colspan="1" valign="top" align="center">234625297</td><td rowspan="1" colspan="1" valign="top" align="center">intronic</td><td rowspan="1" colspan="1" valign="top" align="center">C/T</td><td rowspan="1" colspan="1" valign="top" align="center">0.295</td><td rowspan="1" colspan="1" valign="top" align="center">GWAS</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>3.85×10<sup>-19</sup></strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">0.54</td><td rowspan="1" colspan="1" valign="top" align="center">0.33</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.02</strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.005</strong>
</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs11891311</td><td rowspan="1" colspan="1" valign="top" align="center">234639310</td><td rowspan="1" colspan="1" valign="top" align="center">intronic</td><td rowspan="1" colspan="1" valign="top" align="center">G/A</td><td rowspan="1" colspan="1" valign="top" align="center">0.367</td><td rowspan="1" colspan="1" valign="top" align="center">GWAS</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>6.71×10<sup>-17</sup></strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">0.33</td><td rowspan="1" colspan="1" valign="top" align="center">0.18</td><td rowspan="1" colspan="1" valign="top" align="center">0.06</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.01</strong>
</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs4663965</td><td rowspan="1" colspan="1" valign="top" align="center">234650604</td><td rowspan="1" colspan="1" valign="top" align="center">intronic</td><td rowspan="1" colspan="1" valign="top" align="center">T/C</td><td rowspan="1" colspan="1" valign="top" align="center">0.453</td><td rowspan="1" colspan="1" valign="top" align="center">GWAS</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>1.05×10<sup>-14</sup></strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">0.29</td><td rowspan="1" colspan="1" valign="top" align="center">0.19</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.03</strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.01</strong>
</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs3755319</td><td rowspan="1" colspan="1" valign="top" align="center">234667582</td><td rowspan="1" colspan="1" valign="top" align="center">intronic</td><td rowspan="1" colspan="1" valign="top" align="center">A/C</td><td rowspan="1" colspan="1" valign="top" align="center">0.456</td><td rowspan="1" colspan="1" valign="top" align="center">GWAS</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>8.09×10<sup>-16</sup></strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">0.59</td><td rowspan="1" colspan="1" valign="top" align="center">0.66</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.02</strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.01</strong>
</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs887829</td><td rowspan="1" colspan="1" valign="top" align="center">234668570</td><td rowspan="1" colspan="1" valign="top" align="center">intronic</td><td rowspan="1" colspan="1" valign="top" align="center">C/T</td><td rowspan="1" colspan="1" valign="top" align="center">0.312</td><td rowspan="1" colspan="1" valign="top" align="center">GWAS<sup>§</sup></td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>8.67×10<sup>-20</sup></strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">0.27</td><td rowspan="1" colspan="1" valign="top" align="center">0.13</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.006</strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.001</strong>
</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs6742078</td><td rowspan="1" colspan="1" valign="top" align="center">234672639</td><td rowspan="1" colspan="1" valign="top" align="center">intronic</td><td rowspan="1" colspan="1" valign="top" align="center">C/A</td><td rowspan="1" colspan="1" valign="top" align="center">0.318</td><td rowspan="1" colspan="1" valign="top" align="center">Exome</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>4.44×10<sup>-20</sup></strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">0.41</td><td rowspan="1" colspan="1" valign="top" align="center">0.19</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.007</strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.001</strong>
</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs4148325</td><td rowspan="1" colspan="1" valign="top" align="center">234673309</td><td rowspan="1" colspan="1" valign="top" align="center">intronic</td><td rowspan="1" colspan="1" valign="top" align="center">G/A</td><td rowspan="1" colspan="1" valign="top" align="center">0.318</td><td rowspan="1" colspan="1" valign="top" align="center">Exome</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>4.44×10<sup>-20</sup></strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">0.41</td><td rowspan="1" colspan="1" valign="top" align="center">0.19</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.007</strong>
</td><td rowspan="1" colspan="1" valign="top" align="center">
<strong>0.001</strong>
</td></tr></tbody></table></div><div id="largeobj_idm140105483357376" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3691283/table/T3/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN3"><sup>*</sup>assuming an additive model of inheritance with adjustment for age, sex and T2D affected status</div><div id="TFN4"><sup>†</sup>assuming an additive model of inheritance with adjustment for age, sex and T2D affected status and bilirubin concentrations</div><div id="TFN5"><sup>§</sup>SNPs contained in both the GWAS and Exome sets; results reported for GWAS-derived data</div><div id="TFN6"><sup>¶</sup>SNPs contained in the coding region of the UGT1A6 splice variant</div></div></div></div><div id="S12" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S12title">4. DISCUSSION</h2><p id="P21" class="p p-first">The current study successfully replicated the association of genetic variants in the <em>UGT1A</em> gene cluster with total bilirubin concentrations in a sample enriched for T2D. Although these variants were not associated with measures of vascular calcified plaque at the genome-wide level, modest association with all-cause mortality was observed. Despite these relationships, direct phenotypic correlations were not evident between TBili and either subclinical CVD, or outcome, after accounting for traditional CVD risk factors. However, evidence from this investigation highlights the need for further quantification of the risk for adverse outcomes conferred by genetic variation in the <em>UGT1A</em> family among individuals with T2D.</p><p id="P22">The <em>UGT1A</em> gene cluster association with TBili is biologically plausible. The <em>UGT1A</em> gene cluster encodes the set of uridine diphosphate-glucuronosyltransferase enzymes which are important components of the glucuronidation pathway necessary for the conversion of lipophilic to water soluble molecules for excretion [<a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991688">11</a>, <a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991681">23</a>] (i.e. conversion of unconjugated to conjugated bilirubin). In this way, the <em>UGT1A</em> gene products contribute to the regulation of bilirubin clearance/excretion [<a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991710">4</a>, <a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991692">24</a>] and, as such, to total TBili concentrations. Although a limited number of studies have directly examined the interplay between <em>UGT1A</em> genetic variants and CVD risk and/or outcomes [<a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991685">11</a>, <a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991679">24</a>], we are unaware of any attempts to do this using GWAS identified TBili-associated SNPs. Although able to successfully replicate the association of <em>UGT1A</em> gene cluster with TBili, we did not detect a genome-wide significant relationship between the TBili-associated SNPs and measures of subclinical CVD used in this study. Low penetrance of these genetic variants cannot be discounted here.</p><p id="P23">Studies that have previously examined the association between UGT1A*28 microsatellite and CVD have produced conflicting results. In the Rotterdam Study, the UGT1A1*28 microsatellite was not significantly associated with coronary heart disease, nor were TBili concentrations associated with disease [<a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991706">24</a>]. In contrast, a subsequent investigation in the Framingham Offspring cohort found an association between the UGT1A1*28 microsatellite (rs8175347) and risk for CVD events. The UGT1A1*28 variant associated with increased bilirubin concentrations (i.e. increased microsatellite length) was also associated with a &gt;50% reduction in risk for CVD events over 24 years of follow-up [<a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991707">11</a>], in keeping with the earlier purported negative relationship. Given the proximity of our lead SNP (rs887829) to UGT1A*28 microsatellite (rs8175347) (311bp apart) and the LD structure across the region (based on available HapMap data), we consider it likely that the identified TBili-associated SNPs from the current study are, at minimum, moderately correlated with the previously identified UGT1A*28 microsatellite (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Material, Figure 2</a>). In addition, given their correlated nature, this set of 18 SNPs most likely reflect a single association signal from this region with the causal variant yet to be resolved.</p><p id="P24">Whether the lack of observed association between the <em>UGT1A</em> variants and measures of CVD in the DHS is the result of the T2D-enriched nature of the sample is not clear as the majority of existing studies were not enriched for T2D-affected individuals. When restricting analyses to the DHS T2D-affected individuals only, patterns of association were essentially unchanged although magnitudes were, as expected, generally weaker given the reduction in sample size. There are other differences between this DHS analysis and prior studies. First, the current study utilized measures of vascular calcified plaque, reflecting subclinical CVD, and not verified CVD events as utilized in both the initial epidemiological studies and the Rotterdam [<a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991691">24</a>] and Framingham Offspring [<a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991677">11</a>] cohorts. Use of an intermediate phenotype may be one explanation for the lack of association between both TBili and the <em>UGT1A</em> SNPs, and the chosen measures of CVD. It should be noted however, that the availability of quantitative CAC scores in the DHS should provide enhanced power relative to discrete measures in comparably sized analyses.</p><p id="P25">The seemingly paradoxical association between the <em>UGT1A</em> SNPs and mortality in the absence of a direct phenotypic association between TBili and mortality warrants further consideration. A potential confounding effect of traditional CVD risk factors on the TBili-CVD negative relationship has been acknowledged previously in the context of causal inference [<a href="#R29" rid="R29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991670">29</a>]. Given the excess of CVD risk factors in this T2D-enriched sample, this cannot be discounted. In these analyses, adjustment for TBili increased the strength of the observed genetic associations suggesting that TBili itself may account for some of the otherwise unexplained phenotypic variance. Indeed, our failure to observe similar relationships at the phenotypic level may be the result of lack of control for other elements important in the bilirubin pathway, including albumin transport and the ratio of unconjugated to conjugated bilirubin or insufficient adjustment for residual confounding. For example, a recent report from the National Health and Nutrition Examination Survey found that another measure of liver function, SGPT, was associated with diabetes related mortality and diabetes related heart disease mortality [<a href="#R30" rid="R30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991704">30</a>]. However, we do not observe associations between SGPT and either all-cause or CVD-mortality in the current study (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Material, Table 5</a>) and do not consider it to be a confounding factor here. Lastly, failure to observe direct phenotypic correlations for TBili may be the result of a threshold effect whereby CVD risk is only conferred at very low TBili concentrations (&lt;10 umol/L), as has been reported previously [<a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991703">2</a>, <a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991675">4</a>, <a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_352555972">6</a>]; less than 15% of the DHS sample have TBili concentrations below this value.</p><p id="P26">In addition to phenotypic differences, differences in sample size and age of the cohorts could also contribute to the variable associations observed. Both sample size and age were offered as explanations as to why the <em>UGT1A*28</em> microsatellite was associated with CVD in the larger Framingham (n=1780), but not the smaller Rotterdam study (n=276) [<a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991701">11</a>]. The same factors could also account for the present findings. The mean age at recruitment for the DHS (62 years) is closer to the Rotterdam Study (70 years) than the Framingham Offspring (36 years) and the possibility that the accumulated impact of environmental factors across the life-course masks genetic associations in older cohorts can also not be discounted [<a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991698">11</a>]. The length of follow-up in the DHS was only one-third as long as the Framingham Offspring (~8 years v 24 years), although the overall event rate in Framingham (~19%) was similar to the all-cause mortality rate in the DHS (~21%).</p><p id="P27">Although neither TBili nor the <em>UGT1A</em> SNPs showed compelling association with subclinical CVD in the current study, we did observe a trend for genotypic associations with all-cause mortality. This finding was strengthened upon adjustment for TBili, supporting a contribution of TBili (either directly or as a surrogate for other unknown factors) to the otherwise unexplained phenotypic variance. There was little evidence supporting association between the <em>UGT1A</em> SNPs and CVD-mortality, perhaps simply the result of the low number of CVD-mortality events and resulting reduction in statistical power. In this context, the TBili association with all-cause mortality perhaps alludes to the more global functions of bilirubin as an anti-oxidant [<a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991669">1</a>, <a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991676">4</a>, <a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320991709">12</a>].</p><p id="P28" class="p p-last">In conclusion, the current study confirms the previously identified role of the <em>UGT1A</em> gene family in the regulation of bilirubin concentration. Neither TBili nor the TBili-associated <em>UGT1A</em> SNPs were related to measures of subclinical CVD, however, the trend for association with all-cause mortality alludes to a potential contribution of genetic variation in the <em>UGT1A</em> gene family to risk for mortality in patients with T2D. Further quantification of the extent of CVD risk conferred by genetic variation in the <em>UGT1A</em> family in a high risk sample with T2D is still required.</p></div><div id="unreferenced-ft" class="tsec sec headless whole_rhythm"><div class="unreferenced">​
                    <div class="boxed-text-box whole_rhythm hide-overflow" id="BX1"><div class="caption"><h3 id="idm140105489217424title">Highlights</h3></div><ul class="unordered" style="list-style-type:disc" id="L1"><!--
list-behavior=unordered
prefix-word=
mark-type=disc
max-label-size=0
--><li><p id="__p2"><em>UGT1A</em> gene cluster associated with total bilirubin concentrations in the DHS</p></li><li><p id="__p3">Bilirubin-associated SNPs were not associated vascular calcified plaque</p></li><li><p id="__p4">Bilirubin-associated SNPs were also associated with risk for all-cause mortality</p></li></ul></div></div></div><div id="SM" class="tsec sec"><a id="supplementary-material-sec"></a><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="SMtitle">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="SD1"><h4>01</h4><div class="sup-box half_rhythm" id="d36e636"><a href="/pmc/articles/PMC3691283/bin/NIHMS471000-supplement-01.doc" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(230K, doc)</sup></div></div></div><div id="S13" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S13title">ACKNOWLEDGEMENTS</h2><div class="sec"><p id="__p1">This study was supported in part by R01 HL67348, R01 HL092301, R01 NS058700 (to DWB) and the General Clinical Research Centre of the Wake Forest School of Medicine (M01 RR07122, F32 <a id="__tag_805004130" class="tag_hotlink" href="/nuccore/HL085989" ref="/nuccore/HL085989"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"HL085989","term_id":"1051656397","term_text":"HL085989"}}</span>HL085989</a>). The authors thank the other investigators, the staff, and the participants of the DHS study for their valuable contributions.</p></div></div><div id="idm140105488887968" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140105488887968title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN1"></p><p id="P29" class="p p-first-last"><strong>Publisher's Disclaimer: </strong>This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.</p><p></p><p class="fn sec" id="FN2"></p><p id="P30" class="p p-first">CONFLICT OF INTEREST</p><p id="P31" class="p p-last">The authors declare no conflicts of interest.</p><p></p></div></div><div id="idm140105483999088" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140105483999088title">REFERENCES</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">1. <span class="element-citation">Vitek L. The role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseases. <span><span class="ref-journal">Front Pharmacol. </span>2012;<span class="ref-vol">3</span>:55.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3318228/">PMC free article</a>]</span> [<a href="/pubmed/22493581" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Front+Pharmacol&amp;title=The+role+of+bilirubin+in+diabetes,+metabolic+syndrome,+and+cardiovascular+diseases.&amp;author=L+Vitek&amp;volume=3&amp;publication_year=2012&amp;pages=55&amp;pmid=22493581&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">2. <span class="element-citation">Schwertner HA, Jackson WG, Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. <span><span class="ref-journal">Clin Chem. </span>1994;<span class="ref-vol">40</span>:18–23.</span> [<a href="/pubmed/8287538" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Chem&amp;title=Association+of+low+serum+concentration+of+bilirubin+with+increased+risk+of+coronary+artery+disease.&amp;author=HA+Schwertner&amp;author=WG+Jackson&amp;author=G+Tolan&amp;volume=40&amp;publication_year=1994&amp;pages=18-23&amp;pmid=8287538&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">3. <span class="element-citation">Hopkins PN, Wu LL, Hunt SC, et al.  Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. <span><span class="ref-journal">Arterioscler Thromb Vasc Biol. </span>1996;<span class="ref-vol">16</span>:250–5.</span> [<a href="/pubmed/8620339" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arterioscler+Thromb+Vasc+Biol&amp;title=Higher+serum+bilirubin+is+associated+with+decreased+risk+for+early+familial+coronary+artery+disease.&amp;author=PN+Hopkins&amp;author=LL+Wu&amp;author=SC+Hunt&amp;volume=16&amp;publication_year=1996&amp;pages=250-5&amp;pmid=8620339&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">4. <span class="element-citation">Schwertner HA, Vitek L. Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: Possible protective effects and therapeutic applications of bilirubin. <span><span class="ref-journal">Atherosclerosis. </span>2008;<span class="ref-vol">198</span>:1–11.</span> [<a href="/pubmed/18343383" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Atherosclerosis&amp;title=Gilbert+syndrome,+UGT1A1*28+allele,+and+cardiovascular+disease+risk:+Possible+protective+effects+and+therapeutic+applications+of+bilirubin.&amp;author=HA+Schwertner&amp;author=L+Vitek&amp;volume=198&amp;publication_year=2008&amp;pages=1-11&amp;pmid=18343383&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">5. <span class="element-citation">Vitek L, Jirsa M, Brodanova M, et al.  Gilbert syndrome and ischemic heart disease: A protective effect of elevated bilirubin levels. <span><span class="ref-journal">Atherosclerosis. </span>2002;<span class="ref-vol">160</span>:449–56.</span> [<a href="/pubmed/11849670" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Atherosclerosis&amp;title=Gilbert+syndrome+and+ischemic+heart+disease:+A+protective+effect+of+elevated+bilirubin+levels.&amp;author=L+Vitek&amp;author=M+Jirsa&amp;author=M+Brodanova&amp;volume=160&amp;publication_year=2002&amp;pages=449-56&amp;pmid=11849670&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">6. <span class="element-citation">Novotny L, Vitek L. Inverse relationship between serum bilirubin and atherosclerosis in men: A meta-analysis of published studies. <span><span class="ref-journal">Exp Biol Med. </span>2003;<span class="ref-vol">228</span>:568–71.</span> [<a href="/pubmed/12709588" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Exp+Biol+Med&amp;title=Inverse+relationship+between+serum+bilirubin+and+atherosclerosis+in+men:+A+meta-analysis+of+published+studies.&amp;author=L+Novotny&amp;author=L+Vitek&amp;volume=228&amp;publication_year=2003&amp;pages=568-71&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">7. <span class="element-citation">Tanaka M, Fukui M, Tomiyasu K, et al.  Low serum bilirubin concentration is associated with coronary artery calcification (CAC). <span><span class="ref-journal">Atherosclerosis. </span>2009;<span class="ref-vol">206</span>:287–91.</span> [<a href="/pubmed/19296952" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Atherosclerosis&amp;title=Low+serum+bilirubin+concentration+is+associated+with+coronary+artery+calcification+(CAC).&amp;author=M+Tanaka&amp;author=M+Fukui&amp;author=K+Tomiyasu&amp;volume=206&amp;publication_year=2009&amp;pages=287-91&amp;pmid=19296952&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">8. <span class="element-citation">Moon JS, Chang WJ, Lee CH, et al.  Relationship between serum bilirubin levels and coronary atherosclerosis in patients with type 2 diabetes. <span><span class="ref-journal">Korean Diabetes Journal. </span>2008;<span class="ref-vol">32</span>:338–345.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Korean+Diabetes+Journal&amp;title=Relationship+between+serum+bilirubin+levels+and+coronary+atherosclerosis+in+patients+with+type+2+diabetes.&amp;author=JS+Moon&amp;author=WJ+Chang&amp;author=CH+Lee&amp;volume=32&amp;publication_year=2008&amp;pages=338-345&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">9. <span class="element-citation">Ishizaka N, Ishizaka Y, Takahashi E, Yamakado M, Hashimoto H. High serum bilirubin level is inversely associated with the presence of carotid plaque. <span><span class="ref-journal">Stroke. </span>2001;<span class="ref-vol">32</span>:580–3.</span> [<a href="/pubmed/11157203" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Stroke&amp;title=High+serum+bilirubin+level+is+inversely+associated+with+the+presence+of+carotid+plaque.&amp;author=N+Ishizaka&amp;author=Y+Ishizaka&amp;author=E+Takahashi&amp;author=M+Yamakado&amp;author=H+Hashimoto&amp;volume=32&amp;publication_year=2001&amp;pages=580-3&amp;pmid=11157203&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">10. <span class="element-citation">Neuzil J, Stocker R. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. <span><span class="ref-journal">J Biol Chem. </span>1994;<span class="ref-vol">269</span>:16712–9.</span> [<a href="/pubmed/8206992" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Free+and+albumin-bound+bilirubin+are+efficient+co-antioxidants+for+alpha-tocopherol,+inhibiting+plasma+and+low+density+lipoprotein+lipid+peroxidation.&amp;author=J+Neuzil&amp;author=R+Stocker&amp;volume=269&amp;publication_year=1994&amp;pages=16712-9&amp;pmid=8206992&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">11. <span class="element-citation">Lin JP, O'Donnell CJ, Schwaiger JP, et al.  Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study. <span><span class="ref-journal">Circulation. </span>2006;<span class="ref-vol">114</span>:1476–81.</span> [<a href="/pubmed/17000907" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Association+between+the+UGT1A1*28+allele,+bilirubin+levels,+and+coronary+heart+disease+in+the+Framingham+Heart+Study.&amp;author=JP+Lin&amp;author=CJ+O'Donnell&amp;author=JP+Schwaiger&amp;volume=114&amp;publication_year=2006&amp;pages=1476-81&amp;pmid=17000907&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">12. <span class="element-citation">Vitek L, Schwertner HA. The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases. <span><span class="ref-journal">Adv Clin Chem. </span>2007;<span class="ref-vol">43</span>:1–57.</span> [<a href="/pubmed/17249379" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Clin+Chem&amp;title=The+heme+catabolic+pathway+and+its+protective+effects+on+oxidative+stress-mediated+diseases.&amp;author=L+Vitek&amp;author=HA+Schwertner&amp;volume=43&amp;publication_year=2007&amp;pages=1-57&amp;pmid=17249379&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">13. <span class="element-citation">Bowden DW, Lange LA, Langefeld CD, et al.  The relationship between c-reactive protein and subclinical cardiovascular disease in the Diabetes Heart Study (DHS). <span><span class="ref-journal">Am Heart J. </span>2005;<span class="ref-vol">150</span>:1032–8.</span> [<a href="/pubmed/16290992" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+Heart+J&amp;title=The+relationship+between+c-reactive+protein+and+subclinical+cardiovascular+disease+in+the+Diabetes+Heart+Study+(DHS).&amp;author=DW+Bowden&amp;author=LA+Lange&amp;author=CD+Langefeld&amp;volume=150&amp;publication_year=2005&amp;pages=1032-8&amp;pmid=16290992&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">14. <span class="element-citation">Cox AJ, Agarwal S, Herrington DM, et al.  C-reactive protein concentration predicts mortality in type 2 diabetes: The Diabetes Heart Study. <span><span class="ref-journal">Diabet Med. </span>2012;<span class="ref-vol">29</span>:767–70.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4386279/">PMC free article</a>]</span> [<a href="/pubmed/22211818" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabet+Med&amp;title=C-reactive+protein+concentration+predicts+mortality+in+type+2+diabetes:+The+Diabetes+Heart+Study.&amp;author=AJ+Cox&amp;author=S+Agarwal&amp;author=DM+Herrington&amp;volume=29&amp;publication_year=2012&amp;pages=767-70&amp;pmid=22211818&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">15. <span class="element-citation">Harris EH. Elevated liver function test in type 2 diabetes. <span><span class="ref-journal">Clinical Diabetes. </span>2005;<span class="ref-vol">23</span>:115–119.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clinical+Diabetes&amp;title=Elevated+liver+function+test+in+type+2+diabetes.&amp;author=EH+Harris&amp;volume=23&amp;publication_year=2005&amp;pages=115-119&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">16. <span class="element-citation">Dullaart RP, Kappelle PJ, de Vries R. Lower carotid intima media thickness is predicted by higher serum bilirubin in both non-diabetic and type 2 diabetic subjects. <span><span class="ref-journal">Clin Chim Acta. </span>2012;<span class="ref-vol">414</span>:161–5.</span> [<a href="/pubmed/23010146" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Chim+Acta&amp;title=Lower+carotid+intima+media+thickness+is+predicted+by+higher+serum+bilirubin+in+both+non-diabetic+and+type+2+diabetic+subjects.&amp;author=RP+Dullaart&amp;author=PJ+Kappelle&amp;author=R+de+Vries&amp;volume=414&amp;publication_year=2012&amp;pages=161-5&amp;pmid=23010146&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">17. <span class="element-citation">Chan KH, O'Connell RL, Sullivan DR, et al.  Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. <span><span class="ref-journal">Diabetologia. </span>2013;<span class="ref-vol">56</span>:724–36.</span> [<a href="/pubmed/23322233" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetologia&amp;title=Plasma+total+bilirubin+levels+predict+amputation+events+in+type+2+diabetes+mellitus:+The+Fenofibrate+Intervention+and+Event+Lowering+in+Diabetes+(FIELD)+study.&amp;author=KH+Chan&amp;author=RL+O'Connell&amp;author=DR+Sullivan&amp;volume=56&amp;publication_year=2013&amp;pages=724-36&amp;pmid=23322233&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">18. <span class="element-citation">Choi SW, Lee YH, Kweon SS, et al.  Association between total bilirubin and hemoglobin A1c in korean type 2 diabetic patients. <span><span class="ref-journal">J Korean Med Sci. </span>2012;<span class="ref-vol">27</span>:1196–201.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3468756/">PMC free article</a>]</span> [<a href="/pubmed/23091317" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Korean+Med+Sci&amp;title=Association+between+total+bilirubin+and+hemoglobin+A1c+in+korean+type+2+diabetic+patients.&amp;author=SW+Choi&amp;author=YH+Lee&amp;author=SS+Kweon&amp;volume=27&amp;publication_year=2012&amp;pages=1196-201&amp;pmid=23091317&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R19">19. <span class="element-citation">Bosma PJ, Chowdhury JR, Bakker C, et al.  The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. <span><span class="ref-journal">N Engl J Med. </span>1995;<span class="ref-vol">333</span>:1171–5.</span> [<a href="/pubmed/7565971" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=The+genetic+basis+of+the+reduced+expression+of+bilirubin+UDP-glucuronosyltransferase+1+in+Gilbert's+syndrome.&amp;author=PJ+Bosma&amp;author=JR+Chowdhury&amp;author=C+Bakker&amp;volume=333&amp;publication_year=1995&amp;pages=1171-5&amp;pmid=7565971&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">20. <span class="element-citation">Raijmakers MT, Jansen PL, Steegers EA, Peters WH. Association of human liver bilirubin UDP-glucuronyltransferase activity with a polymorphism in the promoter region of the <em>UGT1A1</em> gene. <span><span class="ref-journal">J Hepatol. </span>2000;<span class="ref-vol">33</span>:348–51.</span> [<a href="/pubmed/11019988" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Hepatol&amp;title=Association+of+human+liver+bilirubin+UDP-glucuronyltransferase+activity+with+a+polymorphism+in+the+promoter+region+of+the+UGT1A1+gene.&amp;author=MT+Raijmakers&amp;author=PL+Jansen&amp;author=EA+Steegers&amp;author=WH+Peters&amp;volume=33&amp;publication_year=2000&amp;pages=348-51&amp;pmid=11019988&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R21">21. <span class="element-citation">Bielinski SJ, Chai HS, Pathak J, et al.  Mayo Genome Consortia: A genotype-phenotype resource for genome-wide association studies with an application to the analysis of circulating bilirubin levels. <span><span class="ref-journal">Mayo Clin Proc. </span>2011;<span class="ref-vol">86</span>:606–14.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3127556/">PMC free article</a>]</span> [<a href="/pubmed/21646302" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mayo+Clin+Proc&amp;title=Mayo+Genome+Consortia:+A+genotype-phenotype+resource+for+genome-wide+association+studies+with+an+application+to+the+analysis+of+circulating+bilirubin+levels.&amp;author=SJ+Bielinski&amp;author=HS+Chai&amp;author=J+Pathak&amp;volume=86&amp;publication_year=2011&amp;pages=606-14&amp;pmid=21646302&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R22">22. <span class="element-citation">Johnson AD, Kavousi M, Smith AV, et al.  Genome-wide association meta-analysis for total serum bilirubin levels. <span><span class="ref-journal">Hum Mol Genet. </span>2009;<span class="ref-vol">18</span>:2700–10.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2701336/">PMC free article</a>]</span> [<a href="/pubmed/19414484" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Mol+Genet&amp;title=Genome-wide+association+meta-analysis+for+total+serum+bilirubin+levels.&amp;author=AD+Johnson&amp;author=M+Kavousi&amp;author=AV+Smith&amp;volume=18&amp;publication_year=2009&amp;pages=2700-10&amp;pmid=19414484&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R23">23. <span class="element-citation">Sanna S, Busonero F, Maschio A, et al.  Common variants in the <em>SLCO1B3</em> locus are associated with bilirubin levels and unconjugated hyperbilirubinemia. <span><span class="ref-journal">Hum Mol Genet. </span>2009;<span class="ref-vol">18</span>:2711–8.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2701337/">PMC free article</a>]</span> [<a href="/pubmed/19419973" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Mol+Genet&amp;title=Common+variants+in+the+SLCO1B3+locus+are+associated+with+bilirubin+levels+and+unconjugated+hyperbilirubinemia.&amp;author=S+Sanna&amp;author=F+Busonero&amp;author=A+Maschio&amp;volume=18&amp;publication_year=2009&amp;pages=2711-8&amp;pmid=19419973&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R24">24. <span class="element-citation">Bosma PJ, van der Meer IM, Bakker CT, et al.  UGT1A1*28 allele and coronary heart disease: The Rotterdam Study. <span><span class="ref-journal">Clin Chem. </span>2003;<span class="ref-vol">49</span>:1180–1.</span> [<a href="/pubmed/12816916" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Chem&amp;title=UGT1A1*28+allele+and+coronary+heart+disease:+The+Rotterdam+Study.&amp;author=PJ+Bosma&amp;author=IM+van+der+Meer&amp;author=CT+Bakker&amp;volume=49&amp;publication_year=2003&amp;pages=1180-1&amp;pmid=12816916&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R25">25. <span class="element-citation">Bowden DW, Cox AJ, Freedman BI, et al.  Review of the Diabetes Heart Study (DHS) family of studies: A comprehensively examined sample for genetic and epidemiological studies of type 2 diabetes and its complications. <span><span class="ref-journal">Rev Diabet Stud. </span>2010;<span class="ref-vol">7</span>:188–201.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3061609/">PMC free article</a>]</span> [<a href="/pubmed/21409311" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Rev+Diabet+Stud&amp;title=Review+of+the+Diabetes+Heart+Study+(DHS)+family+of+studies:+A+comprehensively+examined+sample+for+genetic+and+epidemiological+studies+of+type+2+diabetes+and+its+complications.&amp;author=DW+Bowden&amp;author=AJ+Cox&amp;author=BI+Freedman&amp;volume=7&amp;publication_year=2010&amp;pages=188-201&amp;pmid=21409311&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R26">26. <span class="element-citation">Bowden DW, Lehtinen AB, Ziegler JT, et al.  Genetic epidemiology of subclinical cardiovascular disease in the Diabetes Heart Study. <span><span class="ref-journal">Ann Hum Genet. </span>2008;<span class="ref-vol">72</span>:598–610.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4890966/">PMC free article</a>]</span> [<a href="/pubmed/18460048" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Hum+Genet&amp;title=Genetic+epidemiology+of+subclinical+cardiovascular+disease+in+the+Diabetes+Heart+Study.&amp;author=DW+Bowden&amp;author=AB+Lehtinen&amp;author=JT+Ziegler&amp;volume=72&amp;publication_year=2008&amp;pages=598-610&amp;pmid=18460048&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R27">27. <span class="element-citation">Carr JJ, Nelson JC, Wong ND, et al.  Calcified coronary artery plaque measurement with cardiac CT in population-based studies: Standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development In young Adults (CARDIA) study. <span><span class="ref-journal">Radiology. </span>2005;<span class="ref-vol">234</span>:35–43.</span> [<a href="/pubmed/15618373" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Radiology&amp;title=Calcified+coronary+artery+plaque+measurement+with+cardiac+CT+in+population-based+studies:+Standardized+protocol+of+Multi-Ethnic+Study+of+Atherosclerosis+(MESA)+and+Coronary+Artery+Risk+Development+In+young+Adults+(CARDIA)+study.&amp;author=JJ+Carr&amp;author=JC+Nelson&amp;author=ND+Wong&amp;volume=234&amp;publication_year=2005&amp;pages=35-43&amp;pmid=15618373&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R28">28. <span class="element-citation">Carr JJ, Crouse JR, Goff DC, et al.  Evaluation of subsecond gated helical ct for quantification of coronary artery calcium and comparison with electron beam ct. <span><span class="ref-journal">AJR Am J Roentgenol. </span>2000;<span class="ref-vol">174</span>:915–21.</span> [<a href="/pubmed/10749222" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=AJR+Am+J+Roentgenol&amp;title=Evaluation+of+subsecond+gated+helical+ct+for+quantification+of+coronary+artery+calcium+and+comparison+with+electron+beam+ct.&amp;author=JJ+Carr&amp;author=JR+Crouse&amp;author=DC+Goff&amp;volume=174&amp;publication_year=2000&amp;pages=915-21&amp;pmid=10749222&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R29">29. <span class="element-citation">McArdle PF, Whitcomb BW, Tanner K, et al.  Association between bilirubin and cardiovascular disease risk factors: Using mendelian randomization to assess causal inference. <span><span class="ref-journal">BMC Cardiovasc Disord. </span>2012;<span class="ref-vol">12</span>:16.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3313889/">PMC free article</a>]</span> [<a href="/pubmed/22416852" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Cardiovasc+Disord&amp;title=Association+between+bilirubin+and+cardiovascular+disease+risk+factors:+Using+mendelian+randomization+to+assess+causal+inference.&amp;author=PF+McArdle&amp;author=BW+Whitcomb&amp;author=K+Tanner&amp;volume=12&amp;publication_year=2012&amp;pages=16&amp;pmid=22416852&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R30">30. <span class="element-citation">Schooling CM, Kelvin EA, Jones HE. Alanine transaminase has opposite associations with death from diabetes and ischemic heart disease in NAHNES III. <span><span class="ref-journal">Ann Epidemiol. </span>2012;<span class="ref-vol">22</span>:789–98.</span> [<a href="/pubmed/22954960" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Epidemiol&amp;title=Alanine+transaminase+has+opposite+associations+with+death+from+diabetes+and+ischemic+heart+disease+in+NAHNES+III.&amp;author=CM+Schooling&amp;author=EA+Kelvin&amp;author=HE+Jones&amp;volume=22&amp;publication_year=2012&amp;pages=789-98&amp;pmid=22954960&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3691283&amp;issue-id=224302&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#ui-ncbiinpagenav-heading-3">Associated Data</a></li><li><a href="#idm140105483330784title">Abstract</a></li><li><a href="#S5title">1. INTRODUCTION</a></li><li><a href="#S6title">2. METHODS</a></li><li><a href="#S11title">3. RESULTS</a></li><li><a href="#S12title">4. DISCUSSION</a></li><li><a href="#SMtitle">Supplementary Material</a></li><li><a href="#S13title">ACKNOWLEDGEMENTS</a></li><li><a href="#idm140105488887968title">Footnotes</a></li><li><a href="#idm140105483999088title">REFERENCES</a></li></ul></div></div><!--post-content--></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC3691283/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC3691283/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC3691283/pdf/nihms-471000.pdf">PDF (506K)</a></li> | <li><a href="#" data-citationid="PMC3691283" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3691283%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3691283%2F&amp;text=Association%20of%20SNPs%20in%20the%20UGT1A%20gene%20cluster%20with%20total%20bilirubin%20and%20mortality%20in%20the%20Diabetes%20Heart%20Study" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3691283%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="23642732" data-aiid="3691283" data-aid="3691283" data-iid="224302" data-domainid="319" data-domain="nihpa" data-accid="PMC3691283" data-md5="494eb874ea66e2423c79a85dd8dc39a4"><img src="/portal/portal3rc.fcgi/4018218/img/3631476" alt="Loading..." align="absmiddle"> Loading portlets...</div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T10:50:55-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal105&amp;ncbi_phid=CE8C1279DD5595B10000000005C10378&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3691283%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=nihpa&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC3691283/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>